In this study we wanted to confirm and expand what has been established in the literature by characterizing proinflammatory cytokines (IL-1β, TNF-α and IL-6) as well as IL-17A as inflammatory biomarkers of TMD. The gene discussed is IL1B; the disease is temporomandibular joint disorder.